RxDoctor Payments Data

Eleni Lising

Family · Anaheim, CANPI 1568230514

Payments from drug & device makers

$4,868in general payments, 2019–2025

Across 203 payments — averaging $23.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$757
  • Amgen$503
  • Recordati_rare_diseases_inc.$337
  • Novo Nordisk$317
  • Boehringer Ingelheim$276
  • Neurocrine Biosciences, Inc.$272
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,868100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,868 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$66,627
TrulicityDulaglutide41$61,374
MounjaroTirzepatide35$44,775
JardianceEmpagliflozin25$36,761
TradjentaLinagliptin13$9,083
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$598
Levothyroxine Sodium29$319
Atorvastatin Calcium17$161
Rosuvastatin Calcium13$141
Metformin Hcl19$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$757$106,14976 claims
Novo NordiskOzempic$317$66,62749 claims
Boehringer IngelheimJardiance, Tradjenta$276$45,84438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Anaheim

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →